[1]
Bahi, M., Aissaoui, Y., Belhadj, A., Qamouss, Y. and Seddiki, R. 2021. Hydroxyzine revealing acquired neuromuscular weakness in a patient with COVID-19 disease. The Southwest Respiratory and Critical Care Chronicles. 9, 40 (Jul. 2021), 74-76. DOI:https://doi.org/10.12746/swrccc.v9i40.875.